Skip to main content
. Author manuscript; available in PMC: 2013 Apr 24.
Published in final edited form as: Transplantation. 2011 Jun 27;91(12):1386–1391. doi: 10.1097/TP.0b013e31821bf157

TABLE 4.

Graft and patient survival (%) for entire population compared with nondiabetic population

Time
(yr)		 Group 1
(GN: no steroids)		 Group 2
(non-GN: no steroids)		 Group 3
(GN: steroids)		 Group 4
(non-GN: steroids)		 P
Entire population
   N 216 978 260 950
   Graft survival 1 98 94 92 89 0.0007a
3 88 84 87 83
5 81 77 77 75
7 74 70 70 66
   Death-censored graft survival 1 99 97 95 94 0.47
3 91 91 91 91
5 85 87 83 85
7 81 83 78 80
   Patient survival 1 99 96 95 94 <0.0001b
3 96 90 92 89
5 94 86 89 83
7 87 80 84 76
Non-diabetic population
   N 203 446 251 317
   Graft survival 1 98 96 92 91 0.07
3 89 87 87 84
5 81 84 77 77
7 73 78 70 69
   Death-censored graft survival 1 99 97 95 94 0.21
3 92 92 92 90
5 85 89 84 84
7 80 87 78 80
   Patient survival 1 99 98 95 96 0.03c
3 96 93 93 91
5 94 93 89 86
7 87 83 85 80
a

Group 3 vs. 4, P=0.02; group 1 vs. 4, P=0.004.

b

Group 3 vs. 4, P=0.0002; group 2 vs. 4, P=0.03; group 1 vs. 4, P<0.0001.

c

Group 2 vs. 4, P=0.05; group 1 vs. 4, P=0.03.

GN, glomerulonephritis.